For example, the present findings in lipodystrophic mice suggest the feasibility of an alternative FATS-controlled cell-based therapy for lipoatrophic diabetes via combined expression of leptin and adiponectin, which has been shown to completely reverse insulin resistance in lipoatrophic mice (78). The gene discussed is ADIPOQ; the disease is lipoatrophic diabetes.